Key Highlights
- Niki BioSolutions shares closed up 8% at $9.54.
- The company, formerly Aptorum Group Limited, finalized its all-stock business combination with DiamiR Biosciences Corp.
- The transaction included a 1-for-10 share consolidation.
- The company redomesticated from the Cayman Islands to Delaware.
Niki BioSolutions, Inc. (NASDAQ: NIKI) shares closed up 8% at $9.54 after the company, formerly known as Aptorum Group Limited, finalized its all-stock business combination with DiamiR Biosciences Corp.
What Happened
The transaction included a 1-for-10 share consolidation and redomestication from the Cayman Islands to Delaware, establishing the new brand.
Market Reaction
Shares rose 8% following completion of the merger, share consolidation, and redomestication, which together established the company's new corporate identity.
Outlook
The disclosed information does not include additional forward guidance beyond the completed merger, share consolidation, and redomestication.
What did Niki BioSolutions complete?
An all-stock business combination with DiamiR Biosciences Corp., including a 1-for-10 share consolidation and redomestication from the Cayman Islands to Delaware.
What was Niki BioSolutions previously known as?
Aptorum Group Limited.
Why did Niki BioSolutions shares rise 8%?
Shares rose following completion of the merger, share consolidation, and redomestication that established the new brand.






Please wait processing your request...